HOME >> BIOLOGY >> NEWS
Potential genetic testing for substance abuse raises hope, concern

Genetic tests using blood samples already are used to diagnose some diseases and even personalize treatment.

Now it is possible to develop similar tests that reveal a person's potential to become dependent on nicotine or marijuana or have antisocial personality disorder, University of Iowa researchers report online March 6 in the American Journal of Medical Genetics.

Such tests would not dictate who would become substance dependent or have behavioral problems, as genes do not function in isolation but are influenced by other genes and environmental factors, said the study's lead author Robert Philibert, M.D., Ph.D., professor of psychiatry in the UI Roy J. and Lucille A. Carver College of Medicine.

"Our study suggests that analyzing the expression of genes in blood could indicate whether a person is susceptible to having a behavioral disorder. Having a particular gene expression change does not by itself predict that a person will act a certain way. However, it can indicate who might have a greater biological basis for engaging in behaviors such as smoking and alcohol or marijuana use," Philibert said.

"What matters most is not whether you have a particular gene but whether the gene is expressed, and what other environmental factors may be at play. Genetic variation in and of itself is not deterministic," he added.

In a related study also published online March 6, Philibert and colleagues reported a potential blood test for panic disorder. Both the panic disorder study and one on substance abuse used data from the Iowa Adoption Studies, which were established by Remi Cadoret, M.D., an internationally renowned UI professor of psychiatry who passed away in 2005.

In this latest study, the researchers found certain differences in the genes of people with a history of smoking compared to those without such a history. In all, 579 genes were more expressed and 584 genes were less expressed in people who had
'"/>

Contact: Becky Soglin
becky-soglin@uiowa.edu
319-335-6660
University of Iowa
6-Mar-2007


Page: 1 2 3

Related biology news :

1. Potential for malaria transmission higher than previously thought
2. Potential new therapeutic target for asthma, allergies and cancer
3. Potential diagnostic marker indicates effectiveness of anti-angiogenic drugs
4. Potential new treatment strategy for Alzheimers disease and other brain and spinal cord damage
5. Potential vaccine developed for deadly leishmaniasis disease
6. LIAI initiatives battle influenza; Potential bird flu treatment among their findings
7. Potential malaria drug target identified
8. Potentially harmful fluoride levels found in some instant teas
9. Potential new oncogene may be missing link in cancer-causing chain
10. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
11. Does the desire to consume alcohol and tobacco come from our genetic makeup?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2017)... ALLENTOWN, Pa. , March 20, 2017 ... PD 2.0 personal spirometer and Wellness Management System (WMS), ... Founded in 2010, PMD Healthcare is a ... Company with a mission dedicated to creating innovative solutions ... of life. With that intent focus, PMD developed the ...
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, 2017 /PRNewswire/ ... 23andMe , the leading personal genetics company, are ... can now provide customers with personalized nutrition plans that ... biometrics, but also genetic markers impacting how their body ... personalized food decision support platform uses biometrics such as ...
(Date:3/2/2017)... -- Summary This report provides all the information ... and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... , March 22, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage ... drug delivery systems, announced today that Dr. ... deliver a presentation titled, "Oral Insulin for Diabetes ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT announced ... "Company" or "Propellon"), a start-up created by FACIT ... therapeutics. FACIT,s investment, combined with non-dilutive capital, achieves ... The seed funding enables Propellon to accelerate the ... Company for financing and/or entering a strategic partnership ...
(Date:3/22/2017)... 2017   VWR (NASDAQ: VWR), ... and service solutions to laboratory and production ... EPL Archives, Inc., an international biorepository services ... regulated product research, development and commercialization lifecycle ... ancillary services. EPL Archives is widely recognized ...
Breaking Biology Technology:
Cached News: